Skip to content
Merus N.V. logo

Merus N.V. Alternatives & Competitors

12 companies similar to Merus N.V. — Merus was acquired by Genmab. To see what’s new, visit Genmab.

Companies similar to Merus N.V.

Bright Biologics logo — alternative to Merus N.V.

Bright Biologics

Developing bispecific antibody drug to improve cancer treatment.

OncXerna Therapeutics  logo — alternative to Merus N.V.

OncXerna Therapeutics

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...

Trillium Therapeutics Inc. logo — alternative to Merus N.V.

Trillium Therapeutics Inc.

Clinical stage immuno-oncology company developing innovative therapies for the treatment o...

Lytix Biopharma logo — alternative to Merus N.V.

Lytix Biopharma

A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel...

Rival Readout

Competing with Merus N.V.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
OncoResponse logo — alternative to Merus N.V.

OncoResponse

Interrogating for Cures

Biotecnol Limited logo — alternative to Merus N.V.

Biotecnol Limited

Immunotherapies for Life

Prescient Therapeutics logo — alternative to Merus N.V.

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

2seventy bio logo — alternative to Merus N.V.

2seventy bio

It’s about time we think smarter and faster than cancer.

Antharis Therapeutics, Inc. logo — alternative to Merus N.V.

Antharis Therapeutics, Inc.

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...

Xilio Therapeutics, Inc. logo — alternative to Merus N.V.

Xilio Therapeutics, Inc.

Focused on harnessing the immune system to achieve deep and durable clinical responses to...

Biotheus Inc. logo — alternative to Merus N.V.

Biotheus Inc.

To Inspire Each Other and Create Effective Medicines for Humankind

Immunitas Therapeutics logo — alternative to Merus N.V.

Immunitas Therapeutics

The Human Approach to Oncology

About Merus N.V.

Merus N.V., a biotechnology firm founded in 2003, is headquartered in The Netherlands. The company is at the forefront of developing innovative oncology solutions using its proprietary Biclonics® bispecific antibody therapeutics. This pioneering approach enables simultaneous multi-targeted tumor attacks, enhancing the...

Services

Development of Cancer Treatments, Clinical Trials Management, Research and Development in Biotechnology, Multiclonics Therapeutics

Target Customers

Cancer Patients, Healthcare Providers, Medical Researchers, Pharmaceutical Industry

Business keywords

Biclonics®, Bispecific Antibody Therapeutics, Antibody-based Biopharmaceuticals, Oligoclonics Technology, Immuno-oncology, Cancer Treatment, Antibody Engineering, Tumor Cell Inhibition, Immune System Activation, Biomarker Development, Clinical Trials, Oncology Research, Therapeutic Antibodies, Antibody Discovery, Cell Biology

Business Model

B2B, Platform, B2B2B

Revenue Model

Product Sales, Licensing, Performance Based

Frequently Asked Questions

Companies similar to Merus N.V. include Bright Biologics, OncXerna Therapeutics , Trillium Therapeutics Inc., Lytix Biopharma, OncoResponse. They work in Biotechnology and Health Care and share Merus N.V.'s focus on cancer treatment, immuno-oncology and clinical trials.
Bounce Watch lists 12 companies that share Merus N.V.'s industries and are closest to it in business tags, services, target customers, business model and size.
Merus N.V., a biotechnology firm founded in 2003, is headquartered in The Netherlands. The company is at the forefront of developing innovative oncology solutions using its proprietary Biclonics® bispecific antibody therapeutics. This pioneering approach enables simultaneous multi-targeted tumor attacks, enhancing the...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Merus N.V.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Merus N.V. on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout